Company profile
Ignota Labs
Ignota Labs for in silico toxicity prediction.
Updated 06 Jun 2026 16:52
Financial period: 1 Nov 2023 to 31 Oct 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
MA | Transaction MzQ1NTQ1NDkyMGFkaXF6a2N4 | Paper/PDF filed
Published 20 Feb 2025 06:01
Last accounts made up date
CS01 | Transaction MzQ0MDgzMTQ2OGFkaXF6a2N4
Published 24 Oct 2024 11:31
Company registered at Companies House
1 Dec 2024 to 31 Mar 2026
I am Layla Hosseini-Gerami, a passionate advocate for diversity in tech and science and a proud co-founder of Ignota Labs. As a female ethnic minority with a PhD in AI for Drug Discovery from Cambridge University, where I won the Outstanding Thesis of the Year, I am committed to being a role model for women in tech. My journey has been driven by a desire ...
1 Jul 2023 to 31 Mar 2024
AbsoluteAi is a Machine Learning PharmaTech startup developing innovative data-driven tools to disrupt the discovery toxicology market. Our tools enable early-stage drug discovery scientists to gain drug safety insights not possible with traditional methods, **making drug discovery more efficient**. This project will build on AbsoluteAi's early-stage proo...
